Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300073590Phase 4Completed
Phase 4, randomised, double-blind trial of alfentanil in gynaecological conditions (4 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Plasma norepinephrine (NE) levels. Started Jul 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300073590.